Last week there was another article on patients getting early access to drugs not yet approved by the FDA. Who would this benefit more? Patients or Drug Companies? I think it’s a way better deal for patients. It leaves pharma totally exposed to the chance that a few individuals, if they had adverse events, could rock the boat and jeopardize the medicines chance of FDA approval. That being said, if I was dying or terribly depressed again, and there was a new drug or new class of drug that had positive metrics, I’d sure want access.
There has been so much medical innovation lately..it’s hard to fathom.